BRPI0812909A2 - Derivados de guanina policíclica e métodos de uso dos mesmos. - Google Patents

Derivados de guanina policíclica e métodos de uso dos mesmos.

Info

Publication number
BRPI0812909A2
BRPI0812909A2 BRPI0812909-6A2A BRPI0812909A BRPI0812909A2 BR PI0812909 A2 BRPI0812909 A2 BR PI0812909A2 BR PI0812909 A BRPI0812909 A BR PI0812909A BR PI0812909 A2 BRPI0812909 A2 BR PI0812909A2
Authority
BR
Brazil
Prior art keywords
policyclic
methods
guanine derivatives
guanine
derivatives
Prior art date
Application number
BRPI0812909-6A2A
Other languages
English (en)
Inventor
Deen Tulshian
Willaim B Geiss
Gregory S Martin
Duc Van Le
James C Haber
Julius J Matasi
Michael F Czarniecki
Stephanie Nicole Cooke
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of BRPI0812909A2 publication Critical patent/BRPI0812909A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0812909-6A2A 2007-06-21 2008-06-18 Derivados de guanina policíclica e métodos de uso dos mesmos. BRPI0812909A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94545207P 2007-06-21 2007-06-21
PCT/US2008/007592 WO2009002423A2 (en) 2007-06-21 2008-06-18 Polycyclic guanine derivatives and use thereof

Publications (1)

Publication Number Publication Date
BRPI0812909A2 true BRPI0812909A2 (pt) 2014-12-09

Family

ID=40186205

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0812909-6A2A BRPI0812909A2 (pt) 2007-06-21 2008-06-18 Derivados de guanina policíclica e métodos de uso dos mesmos.

Country Status (17)

Country Link
US (1) US8349858B2 (pt)
EP (1) EP2170896A2 (pt)
JP (1) JP2010530427A (pt)
KR (1) KR20100023040A (pt)
AR (1) AR067060A1 (pt)
AU (1) AU2008269177A1 (pt)
BR (1) BRPI0812909A2 (pt)
CA (1) CA2691194A1 (pt)
CL (1) CL2008001835A1 (pt)
CO (1) CO6251257A2 (pt)
EC (1) ECSP099822A (pt)
IL (1) IL202754A0 (pt)
MX (1) MX2010000098A (pt)
PE (1) PE20090418A1 (pt)
RU (1) RU2010101611A (pt)
TW (1) TW200911817A (pt)
WO (1) WO2009002423A2 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2523561A4 (en) * 2009-12-22 2013-06-05 Merck Sharp & Dohme 7,8-DIHYDRO-1H-IMIDAZO [2,1-B] PURINE-4 (5H) -ONE DERIVATIVES AND METHOD OF USE
WO2012078448A1 (en) * 2010-12-06 2012-06-14 Schering Corporation Tricyclic heterocycles useful as dipeptidyl peptidase-iv inhibitors
TWI589576B (zh) 2011-07-15 2017-07-01 諾華公司 氮雜－雙環二芳基醚之鹽類及製造彼等或其前驅物之方法
MX341834B (es) * 2011-12-30 2016-09-05 Dow Agrosciences Llc Metodos de formacion de esteres pinacolicos de acido 4-cloro-2-fluoro-3-sustituido-fenilboronico y sus metodos de uso.
DK2948148T3 (da) * 2013-01-28 2020-10-26 Incozen Therapeutics Pvt Ltd Metoder til behandling af autoimmune, åndedræts- og betændelsesforstyrrelser ved inhalation af roflumilast n-oxid
TWI627174B (zh) 2013-03-14 2018-06-21 比利時商健生藥品公司 Ｐ２ｘ７調控劑
JP6294953B2 (ja) 2013-03-14 2018-03-14 ヤンセン ファーマシューティカ エヌ．ベー． Ｐ２ｘ７調節物質
TWI644671B (zh) 2013-03-14 2018-12-21 比利時商健生藥品公司 Ｐ２ｘ７調節劑
WO2014152537A1 (en) * 2013-03-14 2014-09-25 Janssen Pharmaceutica Nv P2x7 modulators
EA201790600A1 (ru) 2014-09-12 2017-07-31 Янссен Фармацевтика Нв Модулирующие p2x7 n-ацил-триазолопиразины
JP6592510B2 (ja) 2014-09-12 2019-10-16 ヤンセン ファーマシューティカ エヌ．ベー． Ｐ２ｘ７調節因子
JP6358639B2 (ja) 2015-04-24 2018-07-18 塩野義製薬株式会社 ６員複素環誘導体およびそれらを含有する医薬組成物
MX393004B (es) * 2016-10-17 2025-03-24 Shionogi & Co Derivado heterociclico nitrogenado biciclico y composicion farmaceutica que lo contiene.
WO2020065614A1 (en) 2018-09-28 2020-04-02 Janssen Pharmaceutica Nv Monoacylglycerol lipase modulators
CN113164459B (zh) 2018-09-28 2024-09-03 詹森药业有限公司 单酰基甘油脂肪酶调节剂
ES3037365T3 (en) 2019-09-30 2025-10-01 Janssen Pharmaceutica Nv Radiolabelled mgl pet ligands
BR112022019077A2 (pt) 2020-03-26 2022-12-27 Janssen Pharmaceutica Nv Moduladores da monoacilglicerol lipase

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0119372A1 (en) 1983-03-21 1984-09-26 Svecia Silkscreen Maskiner AB Conveying device using a number of rollers
IL98559A0 (en) * 1990-06-21 1992-07-15 Schering Corp Polycyclic guanine derivatives
NZ262797A (en) * 1993-02-26 1997-08-22 Schering Corp Polycyclic guanine derivatives, purine and pyrimidine precursors; medicaments
EP0760850A1 (en) 1994-05-27 1997-03-12 Glaxo Group Limited P2x RECEPTORS (PURINOCEPTOR FAMILY)
US5856129A (en) 1996-10-30 1999-01-05 Incyte Pharmaceuticals, Inc. DNA encoding a human purinoceptor
WO1999055901A2 (en) 1998-04-30 1999-11-04 Abbott Laboratories Screening assay for identifying human purinoreceptor ligands
WO2002031508A1 (en) 2000-10-13 2002-04-18 Bristol-Myers Squibb Company Methods for detecting modulators of ion channels using thallium (i) sensitive assays
US20020182646A1 (en) 2001-04-30 2002-12-05 Ke Huazhu Methods and products for identifying modulators of P2X7 receptor activity, and their use in the treatment of skeletal disorders
ATE395349T1 (de) * 2001-08-28 2008-05-15 Schering Corp Polycyclische guanin phosphodiesterase inhibitoren
US20050238650A1 (en) 2002-04-17 2005-10-27 Genentech, Inc. Compositions and methods for the treatment of tumor of hematopoietic origin
US20050123925A1 (en) 2002-11-15 2005-06-09 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
CA2465893A1 (en) * 2001-11-09 2003-05-22 Schering Corporation Polycyclic guanine derivative phosphodiesterase v inhibitors
US7560243B2 (en) 2003-04-21 2009-07-14 Wisconsin Alumni Research Foundation White blood cell functional assay
GB0323147D0 (en) 2003-10-03 2003-11-05 Medical Res Council Improvements in or relating to concentration of intracellular agents
EP2305258A3 (en) 2005-05-31 2011-07-06 Duska Scientific Co Inhibition of neuronal damage
WO2007115192A2 (en) 2006-03-31 2007-10-11 Abbott Laboratories P2x7 antagonists to treat affective disorders

Also Published As

Publication number Publication date
AU2008269177A1 (en) 2008-12-31
TW200911817A (en) 2009-03-16
JP2010530427A (ja) 2010-09-09
WO2009002423A3 (en) 2009-04-23
EP2170896A2 (en) 2010-04-07
WO2009002423A2 (en) 2008-12-31
MX2010000098A (es) 2010-04-21
US20110065738A1 (en) 2011-03-17
KR20100023040A (ko) 2010-03-03
US8349858B2 (en) 2013-01-08
RU2010101611A (ru) 2011-07-27
CA2691194A1 (en) 2008-12-31
PE20090418A1 (es) 2009-04-18
CO6251257A2 (es) 2011-02-21
IL202754A0 (en) 2010-06-30
CL2008001835A1 (es) 2008-12-26
ECSP099822A (es) 2010-01-29
AR067060A1 (es) 2009-09-30

Similar Documents

Publication Publication Date Title
BRPI0812909A2 (pt) Derivados de guanina policíclica e métodos de uso dos mesmos.
BRPI0815811A2 (pt) Derivados de indol substituído e métodos de uso dos mesmos
CR10743A (es) Derivados de azaadamantano y metodos de uso de los mismos
BRPI0720625A2 (pt) Derivados de indol de 4,5-anel anulados e métodos de uso dos mesmos
BR112012003661A2 (pt) "compostos de biarila e métodos de uso dos mesmos."
BRPI1010024A2 (pt) derivados de aminopirrolidinona e uso dos mesmos
BRPI0813355A2 (pt) Compostos de quinazolinona e métodos de uso dos mesmos
BRPI0811635A2 (pt) Compostos de arilazol-2-il cianoetilamino, métodos para fazê-los e métodos para o uso dos mesmos
BRPI0916769A2 (pt) derivados de benzilbenzeno deuterados e métodos de uso
BRPI0920927A2 (pt) derivados de azaquinolinona e usos dos mesmos
BRPI0813627A2 (pt) Peptídio antimicrobiano, composições e métodos de uso
BRPI0807495A2 (pt) Adjuvantes e métodos de emrpego dos mesmos
CR10709A (es) Determinadas amidas sustituidas, metodo de elaboracion y metodo de uso de las mismas
BRPI0808013A2 (pt) Compostos de quinoxalina e uso dos mesmos
BRPI0714793A2 (pt) Análogos de niacina não enrubecedores e método de uso dos mesmos.
BRPI0909954A2 (pt) "diazacarbazóis e métodos de uso"
DE602007010981D1 (de) Cycloalkylaminsubstituierte isochinolin- und isochinolinonderivate
BRPI0918502A2 (pt) aminoindanos substituídos e análogos dos mesmos, e o uso farmacêutico dos mesmos
BRPI0907453A2 (pt) Compostos, uso e preparação dos mesmos
BRPI0820457A2 (pt) Fluidos de ruptura e métodos de uso dos mesmos
DOP2010000260A (es) Derivado heterociclico fusionado y su uso
BRPI0909077A2 (pt) Artigos multicamadas e métodos de preparo e uso dos mesmos
BRPI0811865A2 (pt) Derivados heterocíclicos pirrolo-nitrogenados, a preparação e o uso farmacêutico dos mesmos
MA28903B1 (fr) Derives de metastine et leur utilisation
BRPI0720124A2 (pt) Composições farmacêuticas e seus métodos de uso.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]